200 related articles for article (PubMed ID: 29565467)
1. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells.
Mao L; Chen Q; Gong K; Xu X; Xie Y; Zhang W; Cao H; Hu T; Hong X; Zhan YY
Oncol Rep; 2018 May; 39(5):2436-2442. PubMed ID: 29565467
[TBL] [Abstract][Full Text] [Related]
2. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
Cai X; Ding H; Liu Y; Pan G; Li Q; Yang Z; Liu W
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):119-127. PubMed ID: 28069585
[TBL] [Abstract][Full Text] [Related]
3. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
[TBL] [Abstract][Full Text] [Related]
4. Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells.
Lu Y; Wang B; Shi Q; Wang X; Wang D; Zhu L
Sci Rep; 2016 Dec; 6():39123. PubMed ID: 27982118
[TBL] [Abstract][Full Text] [Related]
5. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y
Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway.
Wang L; Yu Z; Ren S; Song J; Wang J; Du G
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2281-2292. PubMed ID: 30036603
[TBL] [Abstract][Full Text] [Related]
7. BMP9 mediates the anticancer activity of evodiamine through HIF‑1α/p53 in human colon cancer cells.
Li FS; Huang J; Cui MZ; Zeng JR; Li PP; Li L; Deng Y; Hu Y; He BC; Shu DZ
Oncol Rep; 2020 Feb; 43(2):415-426. PubMed ID: 31894286
[TBL] [Abstract][Full Text] [Related]
8. A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer.
Ma Y; Yu C; Mohamed EM; Shao H; Wang L; Sundaresan G; Zweit J; Idowu M; Fang X
Oncogene; 2016 Nov; 35(47):6132-6142. PubMed ID: 27132509
[TBL] [Abstract][Full Text] [Related]
9. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
[TBL] [Abstract][Full Text] [Related]
10. Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer.
Kim H; Ju JH; Son S; Shin I
FEBS Lett; 2020 Mar; 594(6):1021-1035. PubMed ID: 31736063
[TBL] [Abstract][Full Text] [Related]
11. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
12. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
13. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M
Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777
[TBL] [Abstract][Full Text] [Related]
14. Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism.
Liu YX; Feng JY; Sun MM; Liu BW; Yang G; Bu YN; Zhao M; Wang TJ; Zhang WY; Yuan HF; Zhang XD
Acta Pharmacol Sin; 2019 Jan; 40(1):122-132. PubMed ID: 29925918
[TBL] [Abstract][Full Text] [Related]
15. High PD‑L1 expression drives glycolysis via an Akt/mTOR/HIF‑1α axis in acute myeloid leukemia.
Ma P; Xing M; Han L; Gan S; Ma J; Wu F; Huang Y; Chen Y; Tian W; An C; Sun H; Sun L
Oncol Rep; 2020 Mar; 43(3):999-1009. PubMed ID: 32020232
[TBL] [Abstract][Full Text] [Related]
16. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
[TBL] [Abstract][Full Text] [Related]
18. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
Wu J; Chai H; Xu X; Yu J; Gu Y
Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
Kim SL; Park YR; Lee ST; Kim SW
Int J Oncol; 2017 Dec; 51(6):1809-1820. PubMed ID: 29075793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]